2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
Open Access
- 12 October 2010
- journal article
- practice guideline
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 182 (17), 1864-1873
- https://doi.org/10.1503/cmaj.100771
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Exposure to Oral Bisphosphonates and Risk of Esophageal CancerJAMA, 2010
- Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapyThe Breast, 2010
- Effect of Osteoporosis Treatment on Mortality: A Meta-AnalysisJournal of Clinical Endocrinology & Metabolism, 2010
- Reduction in Fracture Rate and Back Pain and Increased Quality of Life in Postmenopausal Women Treated with Teriparatide: 18-Month Data from the European Forsteo Observational Study (EFOS)Calcified Tissue International, 2009
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisThe New England Journal of Medicine, 2009
- Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate CancerThe New England Journal of Medicine, 2009
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast CancerJournal of Clinical Oncology, 2008
- Clinical Decision Support Tools for Osteoporosis Disease Management: A Systematic Review of Randomized Controlled TrialsJournal of General Internal Medicine, 2008
- Cost-effective osteoporosis treatment thresholds: the United States perspectiveOsteoporosis International, 2008
- Excess mortality following hip fracture: the role of underlying health statusOsteoporosis International, 2007